Takotsubo Cardiomyopathy and Non-ST-Segment Elevation Myocardial Infarction: Predictors of Left Ventricular

Andrew Hinojos1, Thomas E Vanhecke2, Susan Enright1

  • 1Department of Internal Medicine, Genesys Regional Medical Center/Ascension Health, Grand Blanc, MI, USA.

Insights

Takotsubo (TK) cardiomyopathy and peripheral artery disease (PAD) are independent predictors of reduced left ventricular ejection fraction (LVEF) and elevated B-type natriuretic peptide levels in acute coronary syndrome (ACS) patients.

Area of Science:

  • Cardiology
  • Cardiovascular Research

Background:

  • Acute coronary syndrome (ACS) and Takotsubo (TK) cardiomyopathy share similar initial symptoms, potentially leading to left ventricular (LV) dysfunction and heart failure.
  • Distinguishing between non-ST-segment elevation myocardial infarction (NSTEMI) and TK cardiomyopathy is clinically significant for patient management.

Purpose of the Study:

  • To investigate the independent predictors of reduced left ventricular ejection fraction (LVEF) and elevated B-type natriuretic peptide (BNP) levels in patients presenting with ACS.
  • To compare the characteristics and outcomes of patients with TK cardiomyopathy versus NSTEMI.

Main Methods:

  • Retrospective case-control study involving patients aged 18 years and older who presented with ACS and underwent cardiac catheterization.
  • Analysis of patient data including ejection fraction (EF), presence of TK cardiomyopathy, and peripheral artery disease (PAD).

Main Results:

  • The study included 321 patients in the TK group and 1031 in the NSTEMI group.
  • TK cardiomyopathy was associated with significantly worse LV dysfunction (average EF 44.35% vs. 47.36% in NSTEMI, P < .001).
  • TK (OR 2.373) and PAD (OR 2.053) were identified as significant predictors.

Conclusions:

  • TK cardiomyopathy and PAD are independent predictors of LVEF <35% and elevated BNP levels.
  • These findings aid in identifying high-risk ACS patients who may benefit from closer monitoring and tailored interventions.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
36
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
383
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.6K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
67
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
78
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
90